Literature DB >> 17414883

The role of FDG PET in the management of lymphoma: what is the evidence base?

Anna M Kirby1, N George Mikhaeel.   

Abstract

[18F]Fluorodeoxyglucose positron emission tomography (18F-FDG PET) is playing an increasing role in the management of both Hodgkin and non-Hodgkin lymphoma, offering potential advantages in the accuracy of disease assessment at a number of points in the management pathway. This review evaluates the current level of confidence in the use of PET technology in (1) initial staging, (2) the assessment of early response to chemotherapy, (3) the assessment of residual masses at completion of initial treatment, (4) follow-up, and (5) radiotherapy planning.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17414883     DOI： 10.1097/MNM.0b013e3280895e23

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN： 0143-3636            Impact factor:   1.690


  8 in total

1.  A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma.

Authors:  Eldad J Dann; Rachel Bar-Shalom; Ada Tamir; Ron Epelbaum; Irit Avivi; Menachem Ben-Shachar; Diana Gaitini; Jacob M Rowe
Journal:  Haematologica       Date:  2010-04-21       Impact factor: 9.941

2.  Evaluation of the spatial dependence of the point spread function in 2D PET image reconstruction using LOR-OSEM.

Authors:  D Wiant; J A Gersh; M Bennett; J D Bourland
Journal:  Med Phys       Date:  2010-03       Impact factor: 4.071

3.  Clinical utility of ¹⁸F FDG-PET/CT in the detection of bone marrow disease in Hodgkin's lymphoma.

Authors:  S Muzahir; M Mian; I Munir; M K Nawaz; Z S Faruqui; K A Mufti; H Bashir; N Uddin; N Siddiqui; A U R Maaz; M T Mahmood
Journal:  Br J Radiol       Date:  2012-01-03       Impact factor: 3.039

4.  Accessory spleen-like masses in oncology patients: Are they always benign?

Authors:  David Groshar; Hanna Bernstine; Natalia Goldberg; Dorit Stern; Jacob Sosna
Journal:  World J Radiol       Date:  2010-09-28

Review 5.  PET/CT in oncology: for which tumours is it the reference standard?

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

Review 6.  Predictive and prognostic value of FDG-PET.

Authors:  Lioe-Fee de Geus-Oei; Wim J G Oyen
Journal:  Cancer Imaging       Date:  2008-03-25       Impact factor: 3.909

7.  PET/CT in Oncology: Current Status and Perspectives.

Authors:  Johannes Czernin; Martin Allen-Auerbach; David Nathanson; Ken Herrmann
Journal:  Curr Radiol Rep       Date:  2013-05-03

8.  Improved survival time trends in Hodgkin's lymphoma.

Authors:  Matthew Koshy; Andrew Fairchild; Christina H Son; Usama Mahmood
Journal:  Cancer Med       Date:  2016-03-21       Impact factor: 4.452
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.